BIO-RAD Laboratories (NYSE: BIO) revenue
BIO-RAD Laboratories reported revenue of $2,583m for fiscal 2025, 0.7% more than in fiscal 2024 ($2,567m). Since fiscal 2016 its revenue has grown by 24.9%, an average growth of 2.5% a year.
BIO-RAD Laboratories's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2023, −4.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $2,583m | +0.7% | $47.2m | 1.8% |
| 2024 | $2,567m | −3.9% | $269.0m | 10.5% |
| 2023 | $2,671m | −4.7% | $337.8m | 12.6% |
| 2022 | $2,802m | −4.1% | $482.6m | 17.2% |
| 2021 | $2,923m | +14.8% | $500.3m | 17.1% |
| 2020 | $2,546m | +10.1% | $421.3m | 16.6% |
| 2019 | $2,312m | +1.0% | $229.7m | 9.9% |
| 2018 | $2,289m | +6.0% | −$103.3m | −4.5% |
| 2017 | $2,160m | +4.4% | $119.3m | 5.5% |
| 2016 | $2,068m | — | $55.7m | 2.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
BIO-RAD Laboratories revenue compared with its sector
By revenue for its latest fiscal year, BIO-RAD Laboratories ranks 99th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; BIO-RAD Laboratories, 0.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 97th | Envista | $2,720m | 8.3% |
| 98th | Insulet | $2,708m | 30.7% |
| 99th | BIO-RAD Laboratories | $2,583m | 0.7% |
| 100th | Medpace | $2,530m | 20.0% |
| 101st | Chemed | $2,530m | 4.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of BIO-RAD Laboratories
- How much revenue did BIO-RAD Laboratories make in fiscal 2025?
- BIO-RAD Laboratories reported revenue of $2,583m for fiscal 2025, compared with $2,567m in fiscal 2024.
- How much has the revenue of BIO-RAD Laboratories grown?
- Between fiscal 2016 and fiscal 2025 it went from $2,068m to $2,583m: 24.9% more, an average growth of 2.5% a year.
- What was the best year for revenue at BIO-RAD Laboratories?
- Of its last 10 fiscal years, fiscal 2021, with $2,923m.
- Where does BIO-RAD Laboratories rank in its sector by revenue?
- It ranks 99th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for BIO-RAD Laboratories come from?
- From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BIO-RAD Laboratories: the BIO-RAD Laboratories page · annual accounts · net income.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.